This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board to approve September 2026 quarter and half-year results
STYRENIX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 2.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board will meet on October 28, 2026, to approve the company’s standalone and consolidated unaudited results for the quarter and half-year ended September 30, 2026. The share trading window remains closed until October 30, 2026.
No financial figures are disclosed yet. The stock may react to the results and management commentary after October 28.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹993.5 Cr | ₹798.9 Cr | +24.4% |
| Operating profit | ₹36.59 Cr | ₹53.91 Cr | −32.1% |
| Profit after tax | ₹23.17 Cr | ₹44.72 Cr | −48.2% |
| EBITDA margin | 7.2% | 10.7% | −3.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.